Short answer
The Houston-Pasadena-The Woodlands metro had 46 pharmaceutical and medicine manufacturing establishments in 2023, employing 2,388 people at an average annual pay of $95,879 (Census County Business Patterns); 32 of them have fewer than 20 employees. FDA's registration file lists 65 drug establishments in the metro, 24 of them medical gas suppliers. Eli Lilly reported breaking ground on a Houston manufacturing site in 2026. Listed drugmakers based there include Lexicon Pharmaceuticals.
- Harris County has 29 of the metro's 46 drug manufacturing establishments; Fort Bend has 7 and 813 jobs.
- Only about 4 establishments have 100 or more employees, so the metro's average is 51.9 employees per site.
- Five Houston-area registrations in FDA's file are PET radiopharmaceutical producers, including MD Anderson and Houston Methodist's research institute.
- Drug wholesalers (167 establishments, 3,870 employees) employ more people here than drug plants do.
- Lilly's third-quarter 2026 results list a Houston groundbreaking, one of ten US manufacturing sites announced since 2020.
On this page
This page is for people who want to know which drug companies operate in Houston: chemists and operators looking for work, contract manufacturers and suppliers looking for customers, and sellers deciding whether the market is worth a territory. The short answer is that it's small today, specialized, and gaining one very large new employer.
The Census count
County Business Patterns (CBP) 2023, NAICS 3254 (Pharmaceutical and Medicine Manufacturing), Houston-Pasadena-The Woodlands, TX Metro Area (CBSA 26420):
| Measure (2023) | Houston metro |
|---|---|
| Establishments | 46 |
| Employees | 2,388 |
| Annual payroll | $228,959,000 |
| Average employees per establishment | 51.9 |
| Average annual pay | $95,879 |
| Share of US establishments | 1.59% of 2,901 |
| Employees per establishment | Establishments |
|---|---|
| 1 to 4 | 19 |
| 5 to 9 | 8 |
| 10 to 19 | 5 |
| 20 to 49 | 3 |
| 50 to 99 | 7 |
| 100 or more | 4 (derived) |
The Census Bureau withholds every class from 100 employees up for Houston, so the 4 is the total less the published cells. By county, Harris has 29 establishments and 1,276 employees, Fort Bend 7 and 813, Montgomery 6 and 216, and Brazoria 3, with an employee figure the Bureau published but flagged as high-noise (its confidentiality noise moved the value by 5% or more).
By six-digit code, 23 make finished dose pharmaceuticals (978 employees), 13 make medicinal chemicals and botanicals (297), 6 make biologics and 4 make in-vitro diagnostics; the last two employee totals are high-noise.
Each figure is a count of locations with paid staff, not of companies; businesses without employees are excluded. In Houston the code also misses most of the life sciences workforce: the same data shows 167 drug wholesale establishments (NAICS 424210) with 3,870 employees and 92 biotechnology R&D establishments (NAICS 541714) with 877.
What FDA's file shows
FDA's Drug Establishments Current Registration Site (DECRS) is a daily-updated list of sites registered to make or process drugs for the US market. Our count for the metro's counties from the download on 30 October 2026:
| Registered drug establishments | Count |
|---|---|
| All registrations | 65 |
| List manufacturing or API manufacturing | 44 |
| of which medical gas suppliers (our count by firm name) | 24 |
| of which API manufacturing | 6 |
| Pack, label, repack or relabel only | 8 |
| Testing (analysis) only | 6 |
| PET radiopharmaceutical production only | 5 |
| Medicated animal feed | 2 |
More than half of Houston's manufacturing registrations belong to industrial gas and welding supply companies registered to make medical gases. The drug and isotope registrants include Lonza Houston (Houston), AMPAC Fine Chemicals Texas (La Porte), LGM Pharma Solutions (Rosenberg), Kavis Pharma (Sugar Land), Telix IsoTherapeutics Group (Angleton) and Iso-Tex Diagnostics (Alvin). The five PET producers are SOFIE, P.E.T.NET Houston, The Methodist Hospital Research Institute, the University of Texas MD Anderson Cancer Center and RadioMedix (Humble). Treat each entry as the company's own filing rather than an approval.
The new employer: Lilly
Eli Lilly's third-quarter 2026 results release, filed with the SEC on 29 October 2026, lists "Lilly breaks ground in Houston, one of ten U.S. manufacturing sites announced since 2020", and the same release mentions "new manufacturing expansions in Texas and Virginia". None of this shows up in the 2023 Census figures, so treat the counts above as the starting point. For Lilly's size and rank, see the largest pharmaceutical companies.
Listed drugmakers headquartered in Houston
EDGAR shows 11 listed companies in SIC codes 2833 to 2836 with a business address in the metro. All are small; checked in each latest 10-K:
| Company | Headquarters (10-K cover) | Revenue, 2025 | Employees reported |
|---|---|---|---|
| Lexicon Pharmaceuticals | The Woodlands | $49.8 million | 81 |
| Marker Therapeutics | Houston (Texas Medical Center) | $3.5 million | 5 full-time |
| FibroBiologics | Houston | none reported | 15 full-time |
| Tvardi Therapeutics | Sugar Land | none reported | 12 full-time |
| Greenwich LifeSciences | Stafford | none reported | 4 full-time, 9 part-time |
Coya Therapeutics ($7.9 million of 2025 revenue), Moleculin Biotech, CNS Pharmaceuticals and Decoy Therapeutics also give Houston headquarters on their 10-K covers. With headcounts this size, the chief executive or chief operating officer usually signs for outside services.
Checking a Houston drug company
- Texas licences. FDA lists the Texas Department of State Health Services as the state agency that licenses wholesale drug distributors.
- FDA history. FDA's Data Dashboard shows inspections, warning letters and recalls by firm.
- The local network. BioHouston runs life science events, the Greater Houston Partnership is the region's chamber of commerce and economic development organization, with a member directory, and the Texas Medical Center campus is the address Marker and Decoy give on their 10-K covers.
Job seekers should read the size table first: with 32 of 46 sites under 20 employees, most openings in drug manufacturing come from a handful of employers, plus whatever Lilly's new site adds.
Prospecting Houston's drug sites
| Segment | Examples from the records | Who decides |
|---|---|---|
| Contract and API chemical manufacturers | Lonza Houston, AMPAC Fine Chemicals Texas, LGM Pharma Solutions | Site director, quality and engineering leads |
| Radiopharmaceutical and PET producers | MD Anderson, SOFIE, Telix IsoTherapeutics | Radiopharmacy or production manager, radiation safety officer |
| Clinical-stage biotechs | Lexicon, Coya, Marker | Chief executive, chief operating officer or head of clinical operations |
| Medical gas suppliers | 24 registrations | Branch or plant manager |
Worked example: a GMP cleaning contractor
Illustrative example. The contractor and its prices are invented; the counts come from FDA's registration file.
Bayou Clean Rooms (bayoucleanrooms.example) cleans and disinfects controlled areas to GMP standards.
- Build the list. 20 manufacturing registrations that aren't gas suppliers, 8 packagers and 6 testing labs: 34 sites.
- Do the arithmetic. Reaching the facilities or quality lead at 70% gives 24 conversations. If a quarter agree to a walk-through, that's 6, and 2 monthly contracts at $8,000 bring $192,000 a year.
- Add the next wave. The 92 biotechnology R&D establishments and Lilly's construction-stage site come later, with different buyers.
Finding who owns cleaning at each site is the slow part; Bebop researches each company in a list and suggests the person to contact.
Subject: Cleanroom cleaning at [site name] Hi [first name], [Company] is registered with FDA for [operation] at the [town] site. Facilities managers at registered sites often tell us their cleaning vendor is fine until an auditor asks for the logs. We clean classified areas across the Houston metro with documented SOPs, training records and disinfectant rotation. Would a free walk-through next week help you compare? [Your name] [Phone number]
Next step: compare the other big Texas metro in the Dallas pharmaceutical market report.
Sources
- County Business Patterns (CBP), 2023, US Census Bureau, accessed 30 October 2026
- 2023 County Business Patterns datasets (metro file, NAICS 3254, 424210 and 541714), US Census Bureau, accessed 30 October 2026
- Drug Establishments Current Registration Site (DECRS), US Food and Drug Administration, accessed 30 October 2026
- DECRS annual registration status download (drls_reg.zip), US Food and Drug Administration, accessed 30 October 2026
- Eli Lilly and Company third-quarter 2026 results (Form 8-K exhibit), Eli Lilly and Company, via SEC EDGAR, filed 29 October 2026
- Check licensure of wholesale drug distributors and third-party logistics providers, US Food and Drug Administration, accessed 30 October 2026
- FDA Data Dashboard, US Food and Drug Administration, accessed 30 October 2026
- Lexicon Pharmaceuticals Form 10-K for 2025, Lexicon Pharmaceuticals, Inc., via SEC EDGAR, filed 5 March 2026
- Coya Therapeutics Form 10-K for 2025, Coya Therapeutics, Inc., via SEC EDGAR, filed 16 March 2026
- Decoy Therapeutics Form 10-K for 2025, Decoy Therapeutics Inc., via SEC EDGAR, filed 31 March 2026
- Marker Therapeutics Form 10-K for 2025, Marker Therapeutics, Inc., via SEC EDGAR, filed 18 March 2026
- FibroBiologics Form 10-K for 2025, FibroBiologics, Inc., via SEC EDGAR, filed 24 February 2026
- Tvardi Therapeutics Form 10-K for 2025, Tvardi Therapeutics, Inc., via SEC EDGAR, filed 31 March 2026
- Greenwich LifeSciences Form 10-K for 2025, Greenwich LifeSciences, Inc., via SEC EDGAR, filed 1 June 2026
- BioHouston, BioHouston, accessed 30 October 2026
- Greater Houston Partnership, Greater Houston Partnership, accessed 30 October 2026
Written by the Bebop team at Blackpearl Group. Published .
Questions people ask
How many pharmaceutical companies are in Houston?
Census County Business Patterns counted 46 pharmaceutical and medicine manufacturing establishments in the Houston metro in 2023, employing 2,388 people. FDA's drug establishment registration file lists 65 registered sites in the metro, but 24 of those are medical gas suppliers. SEC EDGAR shows 11 listed drug and biological product companies with a Houston-area address, all of them small.
Is Eli Lilly building a plant in Houston?
Yes. Eli Lilly's third-quarter 2026 results release, filed with the SEC on 29 October 2026, lists "Lilly breaks ground in Houston, one of ten U.S. manufacturing sites announced since 2020." The release also mentions new manufacturing expansions in Texas and Virginia. The site isn't reflected in the 2023 Census counts on this page.
What pharmaceutical companies are headquartered in Houston?
Listed drugmakers whose 10-K covers give Houston-area headquarters include Lexicon Pharmaceuticals (The Woodlands), Coya Therapeutics, Marker Therapeutics, FibroBiologics, Moleculin Biotech, CNS Pharmaceuticals and Decoy Therapeutics (Houston), Tvardi Therapeutics (Sugar Land) and Greenwich LifeSciences (Stafford). Lexicon was the largest by 2025 revenue, at $49.8 million, with 81 employees. Every one of them that reports a headcount has fewer than 100 employees.
How much do pharmaceutical manufacturing jobs pay in Houston?
Pharmaceutical and medicine manufacturing establishments in the Houston metro paid $229.0 million to 2,388 employees in 2023, an average of $95,879 a year, according to Census County Business Patterns. The average covers every job at those sites. Drug wholesalers and biotech research labs, which the Census Bureau counts separately, employ more people in the region.